Man Group PLC Agios Pharmaceuticals, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $495,835 - $609,055	24,829 Added 15.96%	180,428 $4.02 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $366,179 - $423,601	-15,032 Reduced 8.81%	155,599 $3.85 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $627,096 - $856,171	29,331 Added 20.76%	170,631 $4.83 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $926,123 - $1.32 Million	42,600 Added 43.16%	141,300 $3.25 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $890,679 - $1.13 Million	35,900 Added 57.17%	98,700 $2.77 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $261,960 - $458,397	-13,427 Reduced 17.61%	62,800 $1.78 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $1.3 Million - $2.4 Million	76,227 New	76,227 $1.69 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $300,799 - $506,212	-10,169 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $1.3 Million - $1.8 Million	-30,946 Reduced 75.27%	10,169 $469,000
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $7.84 Million - $9.23 Million	-150,564 Reduced 78.55%	41,115 $2.27 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $7.04 Million - $9.16 Million	-159,272 Reduced 45.38%	191,679 $9.9 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $298,026 - $417,649	-8,974 Reduced 2.49%	350,951 $15.2 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $8.18 Million - $13.5 Million	241,590 Added 204.16%	359,925 $12.6 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $3.88 Million - $6.02 Million	112,495 Added 1926.28%	118,335 $6.33 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $38,612 - $65,917	-1,225 Reduced 17.34%	5,840 $207,000
Q4 2019 Feb 18, 2020	SELL	$30.08 - $50.59 $660,376 - $1.11 Million	-21,954 Reduced 75.65%	7,065 $337,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $232,761 - $356,182	7,184 Added 32.9%	29,019 $940,000
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $178,123 - $262,729	-3,858 Reduced 15.02%	21,835 $1.09 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $397,850 - $586,292	-8,664 Reduced 25.22%	25,693 $1.73 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $711,027 - $1.27 Million	16,640 Added 93.92%	34,357 $1.58 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $492,874 - $632,340	6,877 Added 63.44%	17,717 $1.37 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $304,595 - $414,128	-4,160 Reduced 27.73%	10,840 $913,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $897,450 - $1.3 Million	15,000 New	15,000 $1.23 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$190 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$186 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$163 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$126 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$95.2 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account